P19-19. MVA vaccines are efficiently cross-presented by DCs and do not enhance HIV replication in DC/T cell cultures

類似資料

• Preclinical Studies of a Modified Vaccinia Virus Ankara-Based HIV Candidate Vaccine: Antigen Presentation and Antiviral Effect
  著者:: Brandler, Samantha, 等
  出版事項: (2010)
• A novel genotype of MVA that efficiently replicates in single cell suspensions
  著者:: Jordan, Ingo, 等
  出版事項: (2013)
• P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting
  著者:: Robinson, HL, 等
  出版事項: (2009)
• NK-pDC cross-talk leads to the generation of mTRAIL+IFN-α+cytotoxic pDCs following HIV-1 infection of pDCs. Consequences on the control of viral replication
  著者:: Saïdi, Héla, 等
  出版事項: (2010)
• Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine
  著者:: Munseri, P, 等
  出版事項: (2012)